Hypopharyngeal cancer medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hypopharyngeal cancer}} | {{Hypopharyngeal cancer}} | ||
{{CMG}} {{AE}}{{G.D.}},{{Faizan}} | {{CMG}} [[Medical|{{AE}}]]{{G.D.}},{{Faizan}} | ||
==Overview== | ==[[Medical|Overview]]== | ||
The medical therapy with the combination of the radiotherapy has been used compared to surgical therapy for the treatment of hypopharyngeal cancer.The optimal therapy for hypopharyngeal cancer depends on the stage at the time of diagnosis. The combined treatment helps with organ preservation. | The [[medical]] [[therapy]] with the combination of the [[radiotherapy]] has been used compared to [[Surgery|surgical]] [[therapy]] for the treatment of hypopharyngeal cancer.The optimal [[therapy]] for hypopharyngeal cancer depends on the stage at the time of the [[diagnosis]]. The combined treatment helps with [[Organ (anatomy)|organ]] preservation. [[Swallowing]], [[speech]] and [[laryngeal]] preservation are important to consider during the treatment. | ||
==Medical Therapy== | ==Medical Therapy== | ||
The medical therapy with radiotherapy has been used compared to surgical therapy for the treatment of hypopharyngeal cancer due to organ preservation.<ref name="pmid19306746">{{cite journal |vauthors=Lefebvre JL, Ang KK |title=Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary |journal=Int. J. Radiat. Oncol. Biol. Phys. |volume=73 |issue=5 |pages=1293–303 |date=April 2009 |pmid=19306746 |doi=10.1016/j.ijrobp.2008.10.047 |url=}}</ref> The optimal therapy for hypopharyngeal cancer depends on the stage at the time of diagnosis. | The [[medical]] [[therapy]] with [[radiotherapy]] has been used compared to surgical [[therapy]] for the treatment of hypopharyngeal cancer due to [[Organ (anatomy)|organ]] preservation.<ref name="pmid19306746">{{cite journal |vauthors=Lefebvre JL, Ang KK |title=Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary |journal=Int. J. Radiat. Oncol. Biol. Phys. |volume=73 |issue=5 |pages=1293–303 |date=April 2009 |pmid=19306746 |doi=10.1016/j.ijrobp.2008.10.047 |url=}}</ref> The optimal [[therapy]] for hypopharyngeal cancer depends on the stage at the time of [[diagnosis]]. The following factors are important to consider: | ||
The following factors are important to consider: | *[[Swallowing]] | ||
*Swallowing | *[[Speech]] | ||
*Speech | *[[Larynx]] | ||
*Larynx | |||
Treatment according to stages is as follows:<ref name="pmid19306746">{{cite journal |vauthors=Lefebvre JL, Ang KK |title=Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary |journal=Int. J. Radiat. Oncol. Biol. Phys. |volume=73 |issue=5 |pages=1293–303 |date=April 2009 |pmid=19306746 |doi=10.1016/j.ijrobp.2008.10.047 |url=}}</ref><ref name="pmid8656441">{{cite journal |vauthors=Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T |title=Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group |journal=J. Natl. Cancer Inst. |volume=88 |issue=13 |pages=890–9 |date=July 1996 |pmid=8656441 |doi= |url=}}</ref><ref name="aaa">Treatment of hypopharyngeal cancer according to stages. http://www.cancer.gov/types/head-and-neck/patient/hypopharyngeal-treatment-pdq#section/_72</ref> | Treatment according to stages is as follows:<ref name="pmid19306746">{{cite journal |vauthors=Lefebvre JL, Ang KK |title=Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary |journal=Int. J. Radiat. Oncol. Biol. Phys. |volume=73 |issue=5 |pages=1293–303 |date=April 2009 |pmid=19306746 |doi=10.1016/j.ijrobp.2008.10.047 |url=}}</ref><ref name="pmid8656441">{{cite journal |vauthors=Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T |title=Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group |journal=J. Natl. Cancer Inst. |volume=88 |issue=13 |pages=890–9 |date=July 1996 |pmid=8656441 |doi= |url=}}</ref><ref name="aaa">Treatment of hypopharyngeal cancer according to stages. http://www.cancer.gov/types/head-and-neck/patient/hypopharyngeal-treatment-pdq#section/_72</ref> | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center" | ||
Line 57: | Line 56: | ||
==Radiation Therapy== | ==Radiation Therapy== | ||
*Radiation therapy is used for early and localized lesions.<ref name="aaa">Treatment of hypopharyngeal cancer according to stages. http://www.cancer.gov/types/head-and-neck/patient/hypopharyngeal-treatment-pdq#section/_72</ref> | *[[Radiation therapy]] is used for early and localized lesions.<ref name="aaa">Treatment of hypopharyngeal cancer according to stages. http://www.cancer.gov/types/head-and-neck/patient/hypopharyngeal-treatment-pdq#section/_72</ref> | ||
*Radiation therapy is used as a single modality treatment in early lesions. | *[[Radiation therapy]] is used as a single modality treatment in early lesions. | ||
*Laser surgery is gradually replacing [[radiotherapy]] for early lesions as the outcome of both are similar while the laser therapy requires a shorter in-patient period following the procedure. | *[[Laser surgery]] is gradually replacing [[radiotherapy]] for early lesions as the outcome of both are similar while the [[laser therapy]] requires a shorter in-patient period following the procedure. | ||
*Thyroid hormone is recommended before and after radiation therapy. | *[[Thyroid]] [[hormone]] is recommended before and after [[radiation therapy]]. | ||
==References== | ==References== |
Revision as of 16:59, 23 January 2019
Hypopharyngeal cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypopharyngeal cancer medical therapy On the Web |
American Roentgen Ray Society Images of Hypopharyngeal cancer medical therapy |
Risk calculators and risk factors for Hypopharyngeal cancer medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Gertrude Djouka, M.D.[2],Faizan Sheraz, M.D. [3]
Overview
The medical therapy with the combination of the radiotherapy has been used compared to surgical therapy for the treatment of hypopharyngeal cancer.The optimal therapy for hypopharyngeal cancer depends on the stage at the time of the diagnosis. The combined treatment helps with organ preservation. Swallowing, speech and laryngeal preservation are important to consider during the treatment.
Medical Therapy
The medical therapy with radiotherapy has been used compared to surgical therapy for the treatment of hypopharyngeal cancer due to organ preservation.[1] The optimal therapy for hypopharyngeal cancer depends on the stage at the time of diagnosis. The following factors are important to consider:
*Swallowing *Speech *Larynx
Treatment according to stages is as follows:[1][2][3]
Stages | Treatment |
---|---|
Stage 1 |
|
Stage 2 |
|
Stage 3 |
|
Stage 4 |
|
Supportive Treatment
Many patients also need swallowing rehabilitation after treatment to help them adjust to the changes in the structure of the throat.
Radiation Therapy
- Radiation therapy is used for early and localized lesions.[3]
- Radiation therapy is used as a single modality treatment in early lesions.
- Laser surgery is gradually replacing radiotherapy for early lesions as the outcome of both are similar while the laser therapy requires a shorter in-patient period following the procedure.
- Thyroid hormone is recommended before and after radiation therapy.
References
- ↑ 1.0 1.1 Lefebvre JL, Ang KK (April 2009). "Larynx preservation clinical trial design: key issues and recommendations-a consensus panel summary". Int. J. Radiat. Oncol. Biol. Phys. 73 (5): 1293–303. doi:10.1016/j.ijrobp.2008.10.047. PMID 19306746.
- ↑ Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T (July 1996). "Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group". J. Natl. Cancer Inst. 88 (13): 890–9. PMID 8656441.
- ↑ 3.0 3.1 Treatment of hypopharyngeal cancer according to stages. http://www.cancer.gov/types/head-and-neck/patient/hypopharyngeal-treatment-pdq#section/_72